Presentation THT 2025 Trials and Tribulations of Xeno-Transplant Presenter: Albert Hicks February 12, 2025
Presentation THT 2025 Strengths and Weaknesses of VHD Quantitation in Clinical Research and Daily Practice Presenter: Rebecca Hahn February 12, 2025
Presentation THT 2025 Sodium Glucose CoTransporter-2 Inhibitor Following Left Ventricular Assist Device Implantation: A Randomized Controlled Trial Presenter: Mary Acosta February 12, 2025
Presentation THT 2025 Role of Molecular Biopsy in Precision Rejection Diagnosis Presenter: Andrea Fernandez-Valledor February 12, 2025
Presentation THT 2025 Relationship Between Pulmonary Artery Diastolic Pressure and Blood Volume in Supine or Seated Positions Presenter: Paula Rambarat February 12, 2025
Presentation THT 2025 Performance of a Remote Speech Analysis Technology to Detect Worsening Heart Failure Events in Ambulatory Patients With Heart Failure Presenter: William Abraham February 12, 2025
Presentation THT 2025 Overview of Residual Risk and Pathophysiological Targets for Devices to Treat Chronic HF Presenter: Marat Fudim February 12, 2025
Presentation THT 2025 Novel Therapeutics in Transplant Management: Belatacept, ECP and Everything in Between Presenter: Nir Uriel February 12, 2025
Presentation THT 2025 Myeloperoxidase Inhibition in Patients With Ischemic or Non-Ischemic Cardiomyopathy and Heart Failure With Reduced Ejection Fraction (MYSTERY-HF) Presenter: Simon Braumann February 12, 2025
Presentation THT 2025 Lessons Learned From RESHAPE-HF-2: An Imager's Perspective Presenter: Ralph von Bardeleben February 12, 2025
Presentation THT 2025 Impact of Hemodynamic Testing and Pulmonary Artery Pressure Monitoring on HeartMate 3 RPM and Medication Adjustments: RAMP-IT-UP 3 Study Presenter: Dor Lotan February 12, 2025
Presentation THT 2025 Impact of Age on Clinical Outcomes Following HeartMate 3 LVAD Implantation: Insights From the MOMENTUM 3 Trial Presenter: Nir Uriel February 12, 2025
Presentation THT 2025 Imaging for Assessing Heart Muscle Disease: State of the Art for Trial Endpoints, Drug Development and Clinical Practice Presenter: Jonathan Weinsaft February 12, 2025
Presentation THT 2025 HFpEF: Can Image Phenotyping Help for Prognostication and Therapy DEevelopment Presenter: Jonathan Cunningham February 12, 2025
Presentation THT 2025 Greater Splanchnic Nerve Ablation for HFpEF Presenter: Sheldon Litwin February 12, 2025
Presentation THT 2025 Effects of AtrioVentricular Interval Modulation (AVIM) Therapy in Subjects With Hypertension and Diastolic Dysfunction Presenter: Marat Fudim February 12, 2025
Presentation THT 2025 Debate: cfDNA Is the Gold Standard for Rejection Screening Presenter: Shelley Hall February 12, 2025
Presentation THT 2025 Debate: Biopsy Is the Gold Standard for Rejection Screening Presenter: Maryjane Farr February 12, 2025
Presentation THT 2025 Controlled Pulmonary Artery Banding for HFrEF (Restore Medical) Presenter: Sean Pinney February 12, 2025